medigraphic.com
ISSN 2500-7106 (Electronic)
ISSN 0123-2576 (Print)
Medicina & Laboratorio

2023, Number 2

<< Back Next >>

Medicina & Laboratorio 2023; 27 (2)

Characterization of the use of lipid emulsions as antidotal therapy in intoxications other than local anesthetics in a high complexity center in Medellin

Molina-Daza IM, Angulo-Castañeda NY, Vallejo-Bocanumen CE

Language: Spanish
References: 21
Page: 111-122
PDF size: 95.68 Kb.


ABSTRACT

Introduction. Intravenous lipid emulsions (IVLE) are non-toxic fatty emulsions with phospholipids, currently approved for use in the treatment of poisoning, specifically those produced by local anesthetics. The purpose of this study is to characterize the use of IVLE in patients over 18 years of age, who presented intoxication by substances and medications other than local anesthetics, in a high complexity hospital in the city of Medellín, during the period between 2015 and 2020. Methodology. A retrospective descriptive study was carried out on cases that received IVLE as a treatment for their poisoning. The clinical records of the study population were reviewed. Information was collected about sociodemographic, clinical and paraclinical variables, and care. Univariate analysis of the variables of interest was performed. Results. Of the total of 1,966 poisonings, 51 (2.6%) cases caused by substances and medications other than local anesthetics, received ELI therapy between 2015 and 2020 and were included in the study. The median age of the participants was 27 years. 74.5% of the participants presented drug poisoning. The average IVLE dose received was 1,036 mL in 24 hours, a lower dose than the one calculated per kilo of weight, which had been on average 1,149 mL. 86.3% (n=44) of the cases presented neurotoxicity, and 76.5% (n=39) presented cardiotoxicity. Neurotoxicity improved in 34.7% and cardiotoxicity in 59.1% of individuals receiving ELI therapy. Conclusion. The application of IVLE was made in people mostly poisoned by antipsychotics, men, young people, less than half had compromised ventilation, and there was improvement in cardiotoxicity and neurotoxicity. There was a difference between the dose received and the one they should have received adjusted for weight.


REFERENCES

  1. Takala J. Introductory report: Decent worksafework, XVIth World Congress on Safety andHealth at Work Vienna: International LabourOrganization (ILO); 2002. Acceso 11 de agostode 2022. Disponible en https://www.ilo.org/public/libdoc/ilo/2002/463016.pdf.

  2. Organización Mundial de la Salud (OMS). Directricespara la lucha contra las intoxicaciones.Ginebra: OMS; 1998. Acceso 10 de agosto de2022. Disponible en https://apps.who.int/iris/handle/10665/41978.

  3. Gummin DD, Mowry JB, Beuhler MC, SpykerDA, Brooks DE, Dibert KW, et al. 2019 AnnualReport of the American Association of PoisonControl Centers' National Poison Data System(NPDS): 37th annual report. Clin Toxicol (Phila)2020;58:1360-1541. https://doi.org/10.1080/15563650.2020.1834219.

  4. Instituto Nacional de Salud (INS). Informe delevento: Intoxicaciones Colombia. Bogotá D.C.:INS; 2018. Acceso 8 de agosto de 2022. Disponibleen https://www.ins.gov.co/buscadoreventos/Informesdeevento/INTOXICACIONES_2018.pdf.

  5. Collado-Coello AK, González-Gámiz G, Gómez-Carril M. Los antídotos en la lucha contralas intoxicaciones. Rev Cubana Farm 2004;38:1.

  6. Foxall G, McCahon R, Lamb J, Hardman JG,Bedforth NM. Levobupivacaine-induced seizuresand cardiovascular collapse treated with Intralipid.Anaesthesia 2007;62:516-518. https://doi.org/10.1111/j.1365-2044.2007.05065.x.

  7. Marhofer P. Guidelines for the management ofsevere local anaesthetic toxicity according tothe Association of Anaesthetists of Great Britainand Ireland (2007). Ultrasound Guidance in RegionalAnaesthesia: Principles and practical implementation,2nd ed: Oxford University Press;2010. p. 221-224.

  8. Tijo AB, Ávila-Álvarez AA. Terapia de emulsiónlipídica intravenosa en intoxicacionesagudas en el paciente pediátrico. Pediatría2016;49:84-94. https://doi.org/10.1016/j.rcpe.2016.08.001.

  9. Lam SH, Majlesi N, Vilke GM. Use of intravenousfat emulsion in the emergency departmentfor the critically Ill poisoned patient.J Emerg Med 2016;51:203-214. https://doi.org/10.1016/j.jemermed.2016.02.008.

  10. Cave G, Harvey M, Willers J, Uncles D, MeekT, Picard J, et al. LIPAEMIC report: results ofclinical use of intravenous lipid emulsion indrug toxicity reported to an online lipid registry.J Med Toxicol 2014;10:133-142. https://doi.org/10.1007/s13181-013-0375-y.

  11. Panchal AR, Bartos JA, Cabañas JG, DonninoMW, Drennan IR, Hirsch KG, et al. Part3. Adult basic and advanced life support:2020 American Heart Association Guidelinesfor Cardiopulmonary Resuscitation andEmergency Cardiovascular Care. Circulation2020;142:S366-s468. https://doi.org/10.1161/cir.0000000000000916.

  12. Gosselin S, Hoegberg LC, Hoffman RS, GraudinsA, Stork CM, Thomas SH, et al. Evidencebasedrecommendations on the use of intravenouslipid emulsion therapy in poisoning. ClinToxicol (Phila) 2016;54:899-923. https://doi.org/10.1080/15563650.2016.1214275.

  13. Peck AW, Stern WC, Watkinson C. Incidenceof seizures during treatment with tricyclicantidepressant drugs and bupropion. J ClinPsychiatry 1983;44:197-201.

  14. Ministerio de Salud y Protección Social(MPSPS). IQEN. Informe quincenal epidemiológiconacional: Perfil epidemiológico de lasintoxicaciones por sustancias químicas en Colombia,2008-2015. Bogotá D.C.: MINSALUD;2017. Acceso 7 de agosto de 2022. Disponibleen https://www.ins.gov.co/buscador/IQEN/IQEN%20vol%2022%202017%20num%202.pdf.

  15. Instituto Nacional de Salud (INS). Informede evento intoxicaciones por sustancias químicas,Colombia, 2020. Bogotá D.C.: INS; 2018.Acceso 15 de agosto de 2022. Disponible enhttps://www.ins.gov.co/buscador-eventos/Informesdeevento/INTOXICACIONES_2020.pdf.

  16. Elgazzar FM, Elgohary MS, Basiouny SM,Lashin HI. Intravenous lipid emulsion as anadjuvant therapy of acute clozapine poisoning.Hum Exp Toxicol 2021;40:1053-1063. https://doi.org/10.1177/0960327120983873.

  17. Lui KC, Chow YF. Safe use of local anaesthetics:prevention and management of systemictoxicity. Hong Kong Med J 2010;16:470-475.

  18. Smolinske S, Hoffman RS, Villeneuve E,Hoegberg LCG, Gosselin S. Utilization of lipidemulsion therapy in fatal overdose cases:an observational study. Clin Toxicol (Phila)2019;57:197-202. https://doi.org/10.1080/15563650.2018.1504954.

  19. Young-Jin S. Mercury. In: Nelson LS, HoffmanRS, Lewin LA, Goldfrank LR, Howland MA, FlomenbaumNE, eds. Goldfrank´s ToxicologicEmergencies. 9th ed. New York: McGraw Hill;

  20. 2011. p. 1299-1306.20. Food and Agriculture Organization (FAO).Panel of experts on pesticida specifications,registration requirements and application standards(6°, 1985, Roma). Report of the sixth meetingheld in Rome. Roma: FAO; 1986.

  21. Global Crop Protection Federation, CropLifeInternational. Guideliness for the safe and effectiveuse of crop protection products. Brucelas:Créasty; 2006. Acceso 10 de agosto de 2022.Disponible en https://croplife.org/wp-content/uploads/pdf_files/Guidelines-for-the-safe-andeffective-use-of-crop-protection-products.pdf.




2020     |     www.medigraphic.com